[18F-FDG PET/CT in staging and restaging cholangiocarcinoma]

Recenti Prog Med. 2013 Jul-Aug;104(7-8):328-35. doi: 10.1701/1315.14570.
[Article in Italian]

Abstract

The prognosis for hepatobiliary malignancies is dismal. Surgery remains the primary curative option. The positron emission tomography/computed tomography (PET/CT) provides simultaneous metabolic and anatomic information on tumors in the same imaging session. The role of PET/CT in detecting hepatobiliary malignancies has not yet been established. The purpose of this review was to examine the literature on the use of PET/CT in cholangiocarcinomas, also in order to improve the preoperative staging and the restaging, for a proper oncology management of patients.

Publication types

  • Review

MeSH terms

  • Artifacts
  • Bile Duct Neoplasms / diagnostic imaging*
  • Bile Duct Neoplasms / pathology
  • Bile Duct Neoplasms / radiotherapy
  • Bile Duct Neoplasms / surgery
  • Bile Ducts, Intrahepatic / diagnostic imaging*
  • Bile Ducts, Intrahepatic / pathology
  • Cholangiocarcinoma / diagnostic imaging*
  • Cholangiocarcinoma / pathology
  • Cholangiocarcinoma / radiotherapy
  • Cholangiocarcinoma / surgery
  • Combined Modality Therapy
  • Diagnostic Errors
  • Embolization, Therapeutic / methods
  • Fluorine Radioisotopes*
  • Fluorodeoxyglucose F18*
  • Hepatectomy
  • Humans
  • Multimodal Imaging / methods*
  • Neoplasm Staging / methods*
  • Radionuclide Imaging
  • Radiopharmaceuticals* / therapeutic use
  • Treatment Outcome
  • Whole Body Imaging / methods
  • Yttrium Radioisotopes / therapeutic use

Substances

  • Fluorine Radioisotopes
  • Radiopharmaceuticals
  • Yttrium Radioisotopes
  • Fluorodeoxyglucose F18